
Relation Therapeutics is an end-to-end biotech company focused on developing transformational medicines by leveraging high-resolution biology, machine learning, and clinical insights. Their core technology, the Lab-in-the-Loop, integrates single-cell analysis, genomics, and machine learning to understand human biology and discover therapies for devastating diseases. The company, founded in January 2020, has secured significant funding, including a $60M seed round and a strategic partnership with GSK, and is actively seeking world-class talent across biology, machine learning, and drug discovery.

Relation Therapeutics is an end-to-end biotech company focused on developing transformational medicines by leveraging high-resolution biology, machine learning, and clinical insights. Their core technology, the Lab-in-the-Loop, integrates single-cell analysis, genomics, and machine learning to understand human biology and discover therapies for devastating diseases. The company, founded in January 2020, has secured significant funding, including a $60M seed round and a strategic partnership with GSK, and is actively seeking world-class talent across biology, machine learning, and drug discovery.
What they do: End-to-end biotech using single-cell multi-omics, functional assays and machine learning to discover medicines
Founding: Founded Jan 2020 by Charles Roberts, Benjamin Swerner, and Jake Taylor-King
Funding signal: Multiple seed rounds including a $35M seed announced Mar 14, 2024 and larger seed activity through 2024–2025
Headquarters: Regent's Place, 338 Euston Road, London NW1 3BG, UK
Human-focused drug discovery for complex diseases (early indication work includes osteoporosis).
2019
Biotechnology Research
35000000
Seed round announced Mar 14, 2024
25000000
Reported $25M round in June 2022
Seed led by Magnetic Ventures (July 2021) per company timeline
“DCVC, Magnetic Ventures, Khosla Ventures, Firstminute Capital, NVentures, ARK Investment Management, Deerfield Management, NVIDIA, Hitachi Investments, Ark Invest”
| Company |
|---|
About Relation Relation is an end-to-end biotech company developing transformational medicines, with technology at our core. Our ambition is to understand human biology in unprecedented ways, discovering therapies to treat some of life’s most devastating diseases. We leverage single-cell multi-omics directly from patient tissue, functional assays, and machine learning to drive disease understanding—from cause to cure.
This year, we embarked on an exciting dual collaboration with GSK to tackle fibrosis and osteoarthritis, while also advancing our own internal osteoporosis programme. By combining our cutting-edge ML capabilities with GSK’s deep expertise in drug discovery, this partnership underscores our commitment to pioneering science and delivering impactful therapies to patients.
We are rapidly scaling our technology and discovery teams, offering a unique opportunity to join one of the most innovative TechBio companies. Be part of our dynamic, interdisciplinary teams, collaborating closely to redefine the boundaries of possibility in drug discovery. Our state-of-the-art wet and dry laboratories, located in the heart of London, provide an exceptional environment to foster interdisciplinarity and turn groundbreaking ideas into impactful therapies for patients.
We are committed to building diverse and inclusive teams. Relation is an equal opportunities employer and does not discriminate on the grounds of gender, sexual orientation, marital or civil partner status, gender reassignment, race, colour, nationality, ethnic or national origin, religion or belief, disability, or age. We cultivate innovation through collaboration, empowering every team member to do their best work and reach their highest potential.
By joining Relation, you will become part of an exceptionally talented team with extraordinary leverage to advance the field of drug discovery. Your work will shape our culture, strategic direction, and, most importantly, impact patients’ lives.
The opportunity
This is a unique opportunity for a data scientist to work on multi-omics data to drive transformative insights into drug discovery. You will have hands-on experience applying computational methods to real-world therapeutic discovery challenges.
As part of the Cross Indication team, you will work across multiple programme areas, applying computational techniques to multi-omics data. This team supports target identification and validation efforts, combining biological insights with state-of-the-art statistical and computational tools.
Your responsibilities
Professionally, you have
Desirable knowledge or experiences
Personally, you are
Join us in this exciting role where your contributions will have a direct impact on advancing our understanding of genetics and disease risk, supporting our mission to get transformative medicines to patients. Together, we're not just doing research; we're setting new standards in the field of machine learning and genetics. The patient is waiting!
Relation Therapeutics is a committed equal opportunities employer. RECRUITMENT AGENCIES: Please note that Relation Therapeutics does not accept unsolicited resumes from agencies. Resumes should not be forwarded to our job aliases or employees. Relation Therapeutics will not be liable for any fees associated with unsolicited CVs.